Huebner J - Search Results

1

Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.

Theilacker C, Kropec A, Hammer F, Sava I, Wobser D, Sakinc T, Codée JD, Hogendorf WF, van der Marel GA, Huebner J. Theilacker C, et al. Among authors: huebner j. J Infect Dis. 2012 Apr 1;205(7):1076-85. doi: 10.1093/infdis/jis022. Epub 2012 Feb 23. J Infect Dis. 2012. PMID: 22362863

2

Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid.

Theilacker C, Kaczynski Z, Kropec A, Fabretti F, Sange T, Holst O, Huebner J. Theilacker C, et al. Among authors: huebner j. Infect Immun. 2006 Oct;74(10):5703-12. doi: 10.1128/IAI.00570-06. Infect Immun. 2006. PMID: 16988246 Free PMC article.

3

Serodiversity of opsonic antibodies against Enterococcus faecalis--glycans of the cell wall revisited.

Theilacker C, Kaczyński Z, Kropec A, Sava I, Ye L, Bychowska A, Holst O, Huebner J. Theilacker C, et al. Among authors: huebner j. PLoS One. 2011 Mar 18;6(3):e17839. doi: 10.1371/journal.pone.0017839. PLoS One. 2011. PMID: 21437253 Free PMC article.

4

Targeting Type IV Secretion System Proteins to Combat Multidrug-Resistant Gram-positive Pathogens.

Laverde D, Probst I, Romero-Saavedra F, Kropec A, Wobser D, Keller W, Grohmann E, Huebner J. Laverde D, et al. Among authors: huebner j. J Infect Dis. 2017 Jun 15;215(12):1836-1845. doi: 10.1093/infdis/jix227. J Infect Dis. 2017. PMID: 28863473

5

Rationale for the development of immunotherapy regimens against enterococcal infections.

Theilacker C, Krueger WA, Kropec A, Huebner J. Theilacker C, et al. Among authors: huebner j. Vaccine. 2004 Dec 6;22 Suppl 1:S31-8. doi: 10.1016/j.vaccine.2004.08.014. Vaccine. 2004. PMID: 15576199 Review.

6

Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides.

Fabretti F, Theilacker C, Baldassarri L, Kaczynski Z, Kropec A, Holst O, Huebner J. Fabretti F, et al. Among authors: huebner j. Infect Immun. 2006 Jul;74(7):4164-71. doi: 10.1128/IAI.00111-06. Infect Immun. 2006. PMID: 16790791 Free PMC article.

7

Glycolipids are involved in biofilm accumulation and prolonged bacteraemia in Enterococcus faecalis.

Theilacker C, Sanchez-Carballo P, Toma I, Fabretti F, Sava I, Kropec A, Holst O, Huebner J. Theilacker C, et al. Among authors: huebner j. Mol Microbiol. 2009 Feb;71(4):1055-69. doi: 10.1111/j.1365-2958.2008.06587.x. Mol Microbiol. 2009. PMID: 19170884 Free article.

8

Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells.

Sava IG, Zhang F, Toma I, Theilacker C, Li B, Baumert TF, Holst O, Linhardt RJ, Huebner J. Sava IG, et al. Among authors: huebner j. J Biol Chem. 2009 Jul 3;284(27):18194-201. doi: 10.1074/jbc.M901460200. Epub 2009 Apr 23. J Biol Chem. 2009. PMID: 19395379 Free PMC article.

9

Deletion of the glycosyltransferase bgsB of Enterococcus faecalis leads to a complete loss of glycolipids from the cell membrane and to impaired biofilm formation.

Theilacker C, Sava I, Sanchez-Carballo P, Bao Y, Kropec A, Grohmann E, Holst O, Huebner J. Theilacker C, et al. Among authors: huebner j. BMC Microbiol. 2011 Apr 6;11:67. doi: 10.1186/1471-2180-11-67. BMC Microbiol. 2011. PMID: 21470413 Free PMC article.

10

Role of mprF1 and mprF2 in the pathogenicity of Enterococcus faecalis.

Bao Y, Sakinc T, Laverde D, Wobser D, Benachour A, Theilacker C, Hartke A, Huebner J. Bao Y, et al. Among authors: huebner j. PLoS One. 2012;7(6):e38458. doi: 10.1371/journal.pone.0038458. Epub 2012 Jun 18. PLoS One. 2012. PMID: 22723861 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters